NEW YORK – February 5, 2025 – The full lineup of late-breaking clinical science to be presented at THT 2025: Technology and Heart Failure Therapeutics is now available online. Organized by the Cardiovascular Research Foundation® (CRF®), this premier international heart failure conference will be held February 11-13, 2025, at the Omni Boston Hotel at the Seaport in Boston, MA. The full program guide can be found at: https://tht2025.crfconferences.com/program-guide.
Now in its fourth year, THT has established itself as a cornerstone in the pursuit of groundbreaking solutions for heart failure treatment. THT 2025 is poised to deliver an unparalleled experience, spotlighting transformative advancements in device- and technology-based therapies alongside drug treatments, setting the standard for advancing patient care and shaping the future of cardiovascular medicine. Designed by an exceptional lineup of program directors, this year’s agenda features exclusive first-release data from pivotal studies, dynamic discussions on controversies in clinical trials, and deep dives into cutting-edge innovations.
The program includes four dedicated sessions with 21 late-breaking clinical science presentations, highlighting transcatheter approaches to managing a wide spectrum of heart failure patients.
Late-Breaking Clinical Science I
Tuesday, February 11, 2025
9:30 AM — 10:45 AM EST
Ensemble A-B | Level 2
Robotic Surgical Technique for Performing Heart Transplant
Feras Khaliel
Left Atrial to Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results
Javed Butler
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial
James E. Udelson
Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis
Gabriel Sayer
Changes in Seated Pulmonary Artery Pressure in Response To Titration Of Heart Failure Medications During Ambulatory Monitoring
Sandip K. Zalawadiya
Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial
Barry Borlaug
Late-Breaking Clinical Science II
Tuesday, February 11, 2025
5:45 PM — 6:45 PM EST
Ensemble A-B | Level 2
Predictors of Improved vs. Worsened Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF Trial
Gregg W. Stone
Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure
Stefan Anker
Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial
Sanjiv J. Shah
Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF
Barry Borlaug
Cardiac Microcurrent Application for the Reversal of Heart Failure
Eduardo Rame
Late-Breaking Clinical Science III
Wednesday, February 12, 2025
8:00 AM — 9:12 AM EST
Ensemble A-B | Level 2
Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study
Navin K. Kapur
Limited Myocardial Necrosis with Intracoronary Supersaturated Oxygen Therapy In Acute Anterior Myocardial Infarction: Initial Experience In Routine Practice
Andreas Schafer
Lower Extremity Lymphatic Flow Is Associated With Diuretic Response And Weight Change (Decongestion) In Acute Heart Failure
Jan Biegus
Transcatheter Pulmonary Artery Banding [PAB] For HFrEF: Two Year Follow Up And Invasive Exercise Hemodynamics From The Ongoing First-In-Human Trial
Sean P. Pinney
A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial
Akshay Desai
Burst Steroid Therapy and Quality of Life in Patients with Acute Heart Failure: Insights From the CORTAHF Trial
Matteo Pagnesi
Late Breaking Clinical Science IV
Thursday, February 13, 2025
7:00 AM — 8:00 AM EST
Ensemble E-F | Level 2
GSN Ablation Reduces Estimated Stressed Blood Volume in HFpEF: Supports REBALANCE-HF Mechanism of Action
Marat Fudim
Real-World Survival Comparison of Symptomatic Patients with Heart Failure Treated with Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)
Andrew Sauer
Impact Of Preoperative Temporary Mechanical Circulatory Support On Durable LVAD Outcomes: An Analysis of the Society Of Thoracic Surgeons National Intermacs Database
Manreet Kanwar
Mitigating Post-Operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study
Anthony Kanelidis
PICS: A Novel Temporary CV Support Device Augmenting BP and Flow
Alex M. K. Rothman
Additional information on THT is available at https://tht2025.crfconferences.com/.
WHY:
Approximately 6.7 million adults in the United States have heart failure. The incidence of heart failure is projected to increase by 46% from 2012 to 2030, affecting more than 8 million people.
In response to this growing health challenge and the rapid advancements in new therapies, CRF® is committed to providing a premier research and educational platform. THT 2025 is designed to showcase cutting-edge diagnostic approaches and advanced technologies for treating diverse forms of heart failure, driving innovation and improving patient outcomes.
WHEN:
February 11-13, 2025
WHERE:
Omni Boston Hotel at the Seaport
450 Summer Street
Boston, MA 02210
HOW TO REGISTER:
Media may apply for registration by emailing jromero@crf.org.
About CRF®
The Cardiovascular Research Foundation® (CRF®) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF’s centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team. For more information, visit www.crf.org.
###